<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38331038</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus B3 HFMD animal models in Syrian hamster and rhesus monkey.</ArticleTitle><Pagination><StartPage>290</StartPage><EndPage>300</EndPage><MedlinePgn>290-300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2024.02.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(24)00011-7</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is the pathogen causing hand, foot and mouth disease (HFMD), which manifests across a spectrum of clinical severity from mild to severe. However, CVB3-infected mouse models mainly demonstrate viral myocarditis and pancreatitis, failing to replicate human HFMD symptoms. Although several enteroviruses have been evaluated in Syrian hamsters and rhesus monkeys, there is no comprehensive data on CVB3. In this study, we have first tested the susceptibility of Syrian hamsters to CVB3 infection via different routes. The results showed that Syrian hamsters were successfully infected with CVB3 by intraperitoneal injection or nasal drip, leading to nasopharyngeal colonization, acute severe pathological injury, and typical HFMD symptoms. Notably, the nasal drip group exhibited a longer viral excretion cycle and more severe pathological damage. In the subsequent study, rhesus monkeys infected with CVB3 through nasal drips also presented signs of HFMD symptoms, viral excretion, serum antibody conversion, viral nucleic acids and antigens, and the specific organ damages, particularly in the heart. Surprisingly, there were no significant differences in myocardial enzyme levels, and the clinical symptoms resembled those often associated with common, mild infections. In summary, the study successfully developed severe Syrian hamsters and mild rhesus monkey models for CVB3-induced HFMD. These models could serve as a basis for understanding the disease pathogenesis, conducting pre-trial prevention and evaluation, and implementing post-exposure intervention.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Suqin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingxue</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wenting</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lixiong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongjie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Jinghan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Zijun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fengmei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: yangfenmei@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shaohui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: shaohuima@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhanlong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences Medical Primate Research Center Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China. Electronic address: hzl@imbcams.com.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="Y">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="Y">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017201" MajorTopicYN="N">Virus Shedding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal models</Keyword><Keyword MajorTopicYN="N">Coxsackievirus B3 (CVB3)</Keyword><Keyword MajorTopicYN="N">Hand foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Rhesus monkey</Keyword><Keyword MajorTopicYN="N">Syrian hamster</Keyword></KeywordList><CoiStatement>Conflict of interest The authors of this study declared that they do not have any conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>0</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38331038</ArticleId><ArticleId IdType="pmc">PMC11074644</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2024.02.001</ArticleId><ArticleId IdType="pii">S1995-820X(24)00011-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alsop J., Flewett T.H., Foster J.R. Hand-foot-and-mouth disease" in Birmingham in 1959. Br. Med. J. 1960;2:1708–1711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2098292</ArticleId><ArticleId IdType="pubmed">13682692</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavalingappa R.H., Arumugam R., Lasrado N., Yalaka B., Massilamany C., Gangaplara A., Riethoven J.J., Xiang S.H., Steffen D., Reddy J. Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection. Mol. Immunol. 2020;124:218–228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363587</ArticleId><ArticleId IdType="pubmed">32615275</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan S., Yang F., Li Y., Zhao Y., Shi L., Qin M., Liu Q., Jin W., Wang J., Chen L., Zhang W., Li Y., Zhang Y., Zhang J., Ma S., He Z., Li Q. Pathogenic analysis of coxsackievirus A10 in rhesus macaques. Virol. Sin. 2022;37:610–618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9437613</ArticleId><ArticleId IdType="pubmed">35777657</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:391–398.</Citation><ArticleIdList><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Rose N.R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 2007;41:118–122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Mao L., Wan Z., Xu R., Ma Y., Shen L., Jin X., Zhang C. High proportion of coxsackievirus B3 genotype A in hand, foot and mouth disease in Zhenjiang, China, 2011–2016. Int. J. Infect. Dis. 2019;87:1–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31330324</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10:629–653.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T., He W., Song D., Zhao K., Wu C., Gao F., Lu H., Gai X., Wang X., Li F., Ji C., Lin X. Experimental SSM-CVB3 infection in macaques. Exp. Mol. Pathol. 2012;92:131–139.</Citation><ArticleIdList><ArticleId IdType="pubmed">22079478</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., Zhang Y., Huang K., Wang J., Tian H., Song Y., Yang Q., Yan D., Zhu S., Yao M., Wang X., Xu W. Two Coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide. BMC Infect. Dis. 2019;19:466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534883</ArticleId><ArticleId IdType="pubmed">31126252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose M., Ogura A. The golden (Syrian) hamster as a model for the study of reproductive biology: past, present, and future. Reprod. Med. Biol. 2018;18:34–39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6332730</ArticleId><ArticleId IdType="pubmed">30655719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoorn B., Tyrrell D.A. On the growth of certain "newer" respiratory viruses in organ cultures. Br. J. Exp. Pathol. 1965;46:109–118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2095265</ArticleId><ArticleId IdType="pubmed">14286939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Q., Gu J., Lu R., Huang C., Hu X., Wu W., Lin D. NMR-based metabolomic analysis of sera in mouse models of CVB3-induced viral myocarditis and dilated cardiomyopathy. Biomolecules. 2022;12:112–125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8773787</ArticleId><ArticleId IdType="pubmed">35053260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N., Reddy J. An overview of the immune mechanisms of viral myocarditis. Rev. Med. Virol. 2020;30:1–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32720461</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Yang Z., Wang Z., Xu Y., Luo S., Yu X., Liu J., Zhou Y., Tong W., Zeng P. The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010–2017: a retrospective study. PLoS One. 2019;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6553746</ArticleId><ArticleId IdType="pubmed">31170178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C., Zhang X., Na R., Shi H., Jiang L., Wang L., Xie Z., Cui P., Xiong X., Liao Y., Zhao S., Gao J., Tang D., Li Q. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology. 2011;412:91–100.</Citation><ArticleIdList><ArticleId IdType="pubmed">21262515</ArticleId></ArticleIdList></Reference><Reference><Citation>Meenakshi S., Kumar V.U., Dhingra S., Murti K. Nasal vaccine as a booster shot: a viable solution to restrict pandemic? Clin Exp Vaccine Res. 2022;11:184–192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9200647</ArticleId><ArticleId IdType="pubmed">35799869</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao J., Chard L.S., Wang Z., Wang Y. Syrian hamster as an animal model for the study on infectious diseases. Front. Immunol. 2019;10:2329–2345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6781508</ArticleId><ArticleId IdType="pubmed">31632404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone K., Lasrado N., Sur M., Reddy J. Vaccines against group B coxsackieviruses and their importance. Vaccines. 2023;11:274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961666</ArticleId><ArticleId IdType="pubmed">36851152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., Fujiwara K., Saitou M., Tsukiyama T. Non-human primates as a model for human development. Stem Cell Rep. 2021;16:1093–1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185448</ArticleId><ArticleId IdType="pubmed">33979596</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix W.A., Jiang B., Maher K., Strobert E., Oberste M.S. Identification of enteroviruses in naturally infected captive primates. Clin Microbiol. 2008;46:2874–2878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2546737</ArticleId><ArticleId IdType="pubmed">18596147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogg M., Jonsson C.B., Camp J.V., Hooper J.W. Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus. Viruses. 2013;5:2704–2720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3856411</ArticleId><ArticleId IdType="pubmed">24217424</ArticleId></ArticleIdList></Reference><Reference><Citation>Phyu W.K., Ong K.C., Wong K.T. A consistent orally-infected hamster model for enterovirus A71 encephalomyelitis demonstrates squamous lesions in the paws, skin and oral cavity reminiscent of hand-foot-and-mouth disease. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729525</ArticleId><ArticleId IdType="pubmed">26815859</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott J., DeBuysscher B.L., Brown K.S., Feldmann H. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters. Viruses. 2014;6:516–523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939469</ArticleId><ArticleId IdType="pubmed">24492621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestak K. Non-human primate models of enteric viral infections. Viruses. 2018;10:544–567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213648</ArticleId><ArticleId IdType="pubmed">30301125</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L., Chen C.Y., Huang D., Wang R., Zhang M., Qian L., Zhu Y., Zhang A.Z., Yang E., Qaqish A., Chumakov K., Kouiavskaia D., Vignuzzi M., Nathanson N., Macadam A.J., Andino R., Kew O., Xu J., Chen Z.W. Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis. J. Virol. 2017;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487571</ArticleId><ArticleId IdType="pubmed">28356537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Bian L., Gao F., Du R., Hu Y., Fu Y., Su Y., Wu X., Mao Q., Liang Z. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis. Antivir. Res. 2019;161:108–115.</Citation><ArticleIdList><ArticleId IdType="pubmed">30503887</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng S., Wei Y., Zhao S.Y., Lin X.Y., Shao Q.M., Wang J. Intestinal detoxification time of hand-foot-and-mouth disease in children with EV71 infection and the related factors. World J Pediatr. 2015;11:380–385.</Citation><ArticleIdList><ArticleId IdType="pubmed">26454441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H., Zhang Y., Sun Q., Zhu S., Li X., Pan Z., Xu W., Xu B. Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses A10 and B3. PLoS One. 2014;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879295</ArticleId><ArticleId IdType="pubmed">24392117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl-Jensen V., Bollinger L., Safronetz D., de Kok-Mercado F., Scott D.P., Ebihara H. Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers. Viruses. 2012;4:3754–3784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528289</ArticleId><ArticleId IdType="pubmed">23242370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Cormier R.T. Golden Syrian hamster models for cancer research. Cells. 2022;11:2395–2412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368453</ArticleId><ArticleId IdType="pubmed">35954238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Yu C.K. Animal models of enterovirus 71 infection: applications and limitations. Biomed. Sci. 2014;21:31–49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang Y., Zhang X., Hu Y., Dong C., Liu L., Yang E., Che Y., Pu J., Wang X., Song J., Liao Y., Feng M., Liang Y., Zhao T., Jiang L., He Z., Lu S., Wang L., Li Y., Fan S., Guo L., Li Q. Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017;500:198–208.</Citation><ArticleIdList><ArticleId IdType="pubmed">27829175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wold W.S.M., Tollefson A.E., Ying B., Spencer J.F., Toth K. Drug development against human adenoviruses and its advancement by Syrian hamster models. FEMS Microbiol. Rev. 2019;43:380–388.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Wang H.Q., Guo T.T., Li Y.H. Luteolin inhibits CVB3 replication through inhibiting inflammation. Asian Nat Prod Res. 2020;22:762–773.</Citation><ArticleIdList><ArticleId IdType="pubmed">31321999</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., Cowling B.J., Varma J.K., Farrar J.J., Leung G.M., Yu H. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 2014;14:308–318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuan L.Y., Tao X.X., Zhao Y.J., Ge H.Y., Bao L.H., Wang D.P., Zhao M. Effect of total flavonoids of astragalus on endoplasmic reticulum chaperone, calumenin and connecxin 43 in suckling mouse myocardium with myocarditis caused by coxsackievirus B3. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2016;32:51–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">27255042</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X., Bian L.L., Lu W.W., Li J.X., Mao Q.Y., Wang Y.P., Gao F., Wu X., Ye Q., Xu M., Li X.L., Zhu F.C., Liang Z.L. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012–2013. J. Med. Virol. 2015;87:2009–2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">26010334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zander A., Britton P.N., Navin T., Horsley E., Tobin S., McAnulty J.M. An outbreak of enterovirus 71 in metropolitan Sydney: enhanced surveillance and lessons learnt. Med. J. Aust. 2014;201:663–666.</Citation><ArticleIdList><ArticleId IdType="pubmed">25495312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H.W., Sun M., Guo L., Wang J.J., Song J., Li J.Q., Li H.Z., Ning R.T., Yang Z.N., Fan H.T., He Z.L., Liu L.D. Nasal infection of enterovirus D68 leading to lower respiratory tract pathogenesis in ferrets (Mustela putorius furo) Viruses. 2017;9:104–119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5454417</ArticleId><ArticleId IdType="pubmed">28489053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>